These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19172689)

  • 1. Perspectives on NMR in drug discovery: a technique comes of age.
    Pellecchia M; Bertini I; Cowburn D; Dalvit C; Giralt E; Jahnke W; James TL; Homans SW; Kessler H; Luchinat C; Meyer B; Oschkinat H; Peng J; Schwalbe H; Siegal G
    Nat Rev Drug Discov; 2008 Sep; 7(9):738-45. PubMed ID: 19172689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.
    Jahnke W
    J Biomol NMR; 2007 Oct; 39(2):87-90. PubMed ID: 17701274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research.
    Caceres-Cortes J; Falk B; Mueller L; Dhar TGM
    J Med Chem; 2024 Feb; 67(3):1701-1733. PubMed ID: 38290426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Solution NMR in Drug Discovery.
    Shi L; Zhang N
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarization Transfer from Ligands Hyperpolarized by Dissolution Dynamic Nuclear Polarization for Screening in Drug Discovery.
    Min H; Sekar G; Hilty C
    ChemMedChem; 2015 Sep; 10(9):1559-63. PubMed ID: 26315550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions in NMR Tubes as Key Weapon in Rational Drug Design.
    Ntountaniotis D
    Methods Mol Biol; 2018; 1824():417-430. PubMed ID: 30039422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NMR screening in fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance-based approaches for lead generation in drug discovery.
    Peng JW; Lepre CA; Fejzo J; Abdul-Manan N; Moore JM
    Methods Enzymol; 2001; 338():202-30. PubMed ID: 11460549
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of NMR in lead optimization: fragment-based approaches.
    Huth JR; Sun C
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):631-43. PubMed ID: 12470260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead Identification Through the Synergistic Action of Biomolecular NMR and In Silico Methodologies.
    Marousis KD; Tsika AC; Birkou M; Matsoukas MT; Spyroulias GA
    Methods Mol Biol; 2018; 1824():299-316. PubMed ID: 30039415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences in fragment-based lead discovery.
    Hubbard RE; Murray JB
    Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.